During Caenorhabditis elegans gonadal development, a stochastic interaction between the LIN-12/Notch receptor and the LAG-2/Delta ligand initiates cell fate specification of two equivalent pre-anchor cell (AC)/pre-ventral uterine (VU) precursor cells. Both cells express lin-12 and lag-2 before specification, and a small difference in LIN-12 activity leads to the exclusive expression of lin-12 in VUs and lag-2 in the AC through an unknown feedback mechanism. In this Notch signaling process, the cleaved LIN-12/Notch intracellular domain (NICD) binds to the LAG-1/CSL transcriptional repressor, forming a transcriptional activator complex containing LAG-1 and NICD. Here we show that clustered LAG-1 binding sites in lin-12 and lag-1 are involved in regulating lin-12 and lag-1 expression during AC/VU cell fate specification. Both genes are expressed in VU cells, but not the AC, after specification. We also show that lin-12 is necessary for lag-1 expression in VU cells. Interestingly, lin-12 (null) animals express lag-1 in the AC, suggesting that LIN-12 signaling is necessary for the suppression of lag-1 expression in the AC. Ectopic expression of lag-1 cDNA in the AC causes a defect in the vulvaluterine (V-U) connection; therefore, LAG-1 should be eliminated in the AC to form a normal V-U connection at a later developmental stage in wild-type animals.
INTRODUCTION
Notch signaling mediates cell-cell interactions of neighboring cells through the interaction between membrane-bound ligand and receptor proteins (Artavanis-Tsakonas et al., 1999) . Thus, it is often involved in specification of fates of cells that are adjacent to each other and originate from common ancestral cells. In some cases, a stochastic difference or any small increase in Notch activity is amplified through feedback loops, which establishes stable states from which cell fate cannot be reverted (Xiong and Ferrell, 2003) .
The binding of the Delta/Serrate ligand to the Notch receptor induces the cleavage of the Notch transmembrane domain by a membrane-bound γ(gamma)-secretase (Greenwald, 2005) . The cleaved Notch intracellular domain (NICD) binds to CSL, a sequence-specific DNA-binding protein that, alone, acts as a transcriptional repressor and, upon NICD binding, becomes an activator (Hsieh et al., 1996; Jarriault et al., 1995) . The fact that CSL can repress or activate the transcription of target genes suggests a model by which Notch signaling achieves cell fate specification through lateral inhibition. In this model, cells expressing Notch at a higher level than neighboring cells will produce more NICDs and, thus, more transcription activator complexes, eventually increasing the expression of CSL target genes. In contrast, neighboring cells expressing less or no Notch will decrease or repress target gene expression. A few CSL target genes involved in cell fate specification have been identified; however, a sufficient number have not been identified to suggest a mechanism for the production of exclusive cell fates by lateral inhibition, or one for the exclusive expression of Notch by one cell and Delta/Serrate by the other (Johnston and Desplan, 2010) .
Because the fate specification of the anchor cell (AC) and a ventral uterine (VU) precursor cell is initiated by a stochastic interaction between LIN-12/Notch and LAG-2/Delta in two neighboring cells in the Caenorhabditis elegans somatic gonad, it has been a good model system to understand the molecular mechanism of Notch-dependent lateral inhibition through which a small difference in Notch activity establishes two exclusive cell fate states that cannot be reverted (Kimble and Simpson, 1997; Seydoux and Greenwald, 1989; Wilkinson et al., 1994) . In wild-type animals, two somatic gonadal cells (Z1.ppp and Z4.aaa) have equal potential to become the AC or a VU and the two cells express both LAG-2 and LIN-12 before specification (Seydoux and Greenwald, 1989; Wilkinson et al., 1994) . After AC/VU specification, one of the cells expresses only LAG-2 and adopts the AC fate, and the other expresses only LIN-12 and becomes a VU cell (Seydoux and Greenwald, 1989; Wilkinson et al., 1994) .
The AC and VU cells have been used not only to study the mechanisms underlying Notch-dependent cell fate specification but also to understand cellular differentiation events. The VU cells undergo four rounds of cell division (Kimble and Hirsh, 1979; Newman and Sternberg, 1996; Newman et al., 1996) ,
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http://molcells.org Established in 1990 Co-regulation of lag-1 and lin-12 Expression by Notch Seong Kyun Park et al. http://molcells.org whereas the AC remains a single cell in the gonad and expresses LIN-3, a member of the epidermal growth factor (EGF) family, that induces patterned proliferation of vulval precursor cells (VPCs) (Hill and Sternberg, 1992) . The AC also invades the vulval epithelium by extending a process toward the 1° lineage (P6.p) of vulval cells (Sherwood and Sternberg, 2003) . fos-1, a C. elegans homolog of the proto-oncogene Fos, is involved in the destruction of the underlying basement membranes during AC invasion (Sherwood et al., 2005) . After the AC has invaded the vulval epithelium, it is involved in the formation of a structure that connects vulva and uterus (New-man and Sternberg, 1996; Newman et al., 1996) . Here, the AC fuses with some of the VU descendents to form a H-shaped structure (utse) in which a thin laminar cytoplasmic bridge separates the upper uterine and lower vulval lumens.
A genome-wide computational search to identify genes coexpressed from a common regulatory element identified egl-43 as a gene co-expressed with lin-3 during AC/VU specification as well as a LIN-12 downstream target (Hwang and Sternberg, 2004; Hwang et al., 2007) . Here, an enhancer element (anchor cell element of lin-3, ACEL) in both lin-3 and egl-43 was sufficient to activate these genes in pre-AC/pre-VU cells and the AC, but not in VU cells. This element consists of two E-boxes and one FTZ-F1 nuclear hormone receptor-(NHR-) binding site (Hwang and Sternberg, 2004) . HLH-2, C. elegans ortholog of mammalian E12/E47 and Drosophila melanogaster Daughterless involved in the exclusive expression of LAG-2 in the AC (Karp and Greenwald, 2003; 2004) , binds to the E-boxes and is necessary for lin-3 transcription in the AC (Hwang and Sternberg, 2004) . Thus, a similar element could activate lag-2 transcription during AC/VU specification. Expression of egl-43 appears to be regulated by several distinct regulatory elements during AC/VU specification and later cellular processes that involve the AC and VU cells (Hwang et al., 2007) . In addition to ACEL, an element that involves clustered LAG-1 binding sites supports egl-43 expression in VU cells immediately after AC/VU specification. This element is also expressed in the VU cells and their descendents as a downstream of the transcription factor FOS-1. Another element supports egl-43 expression in the AC when vulval-uterine connection takes place at early L4 stage (Hwang et al., 2007) .
In previous experiments to dissect the egl-43 regulatory elements, the role of a regulatory element that contains clustered LAG-1 binding sites was not clear due to the presence of an ACEL element that strongly supports gene expression during AC/VU specification (Hwang et al., 2007) . Here, in an attempt to study the role of regulatory elements containing clustered LAG-1 binding sites, we addressed whether clustered LAG-1 binding sites in lag-1 and lin-12 are involved in the expression of these genes during AC/VU specification. Studies using transgenic animals and site-directed mutagenesis clearly show that LAG-1 binding sites in both genes are involved in eliminating their expression in the AC and supporting expression in the pre-AC/pre-VU and VU cells, as well as their descendents. Thus, LAG-1 appears to act as a transcriptional repressor in the AC and as an activator in the VU cells during AC/VU specification. We also show that LIN-12 signaling is necessary for the suppression of lag-1 expression in the AC. To address the significance of the elimination of LAG-1 in the AC, we ectopically expressed lag-1 cDNA in the AC, which caused a defect in V-U connection. Thus lag-1 expression in the AC should be repressed during AC/VU specification for the proper differentiation event to occur at a later developmental stage.
MATERIALS AND METHODS
General methods and strains C. elegans strains were handled, maintained at 20°C, and crossed following standard protocols (Brenner, 1974) . Experiments were conducted at 20°C unless otherwise indicated. Cell anatomy was observed with Nomarski optics, and cyan fluorescent protein (CFP) and yellow fluorescent protein (YFP) expression was detected using a Zeiss Axioplan compound microscope. Micrographs were taken with a Hamamatsu ORCA-ER digital camera and Improvision Openlab software, and images were overlaid using Adobe Photoshop CS.
Transgenic lines were generated using a standard microinjection protocol (Mello et al., 1991) . The lag-1::YFP or lin-12:: YFP construct (25 or 50 ug/ml) was co-injected with the plasmid myo-2::YFP plasmid (5 ug/ml) and pBluescript (170 ug/ml) into unc-119(ed4); syIs57[cdh-3::CFP + pDP#MM016B] or lin-12(n676n909) unc-32(e189)/qC1 animals. The cdh-3 (AC element)::YFP or cdh-3 (AC element)::lag-1 cDNA construct (50 ug/ml) was co-injected with myo-2::YFP plasmid (5 ug/ml) and pBluescript (150 ug/ml), into N2 and kuIs29[unc-119(+) + pWH17(cog-2::gfp)] animals. After injection, animals expressing myo-2::YFP in the pharynx were identified and maintained as transgenic lines.
Constructs lag-1(wild-type)::YFP-PEST and lag-1(mutated LAG-1 binding sites)::YFP-PEST constructs were prepared as follows. The lag-1(wild-type)::YFP-PEST construct, containing wild-type LAG-1 binding sites, was prepared by cloning part of the first intron region of lag-1 into the plasmid pPD122.53(YFP-PEST), which contains NLS 4 ::YFP-PEST. The 1758-bp genomic fragment (aagetttcccatcctagtttttcccacacq ---tqgqaaacccccccaactqqgqaqaaqctt) of lag-1 was PCR-amplified from N2 genomic DNA and cloned into a HindIII site in pPD122.53(YFP-PEST), which contains a PEST sequence from the mouse ornithine decarboxylase gene (amino acids 820-942) downstream of YFP. In the lag-1(mutated LAG-1 binding sites)::YFP-PEST transcriptional fusion construct, a PCR fragment containing mutations in all 13 putative LAG-1-binding sites was cloned into pPD122.53 (YFP-PEST).
The lin-12(wild-type)::YFP transcriptional fusion construct was prepared by cloning a PCR-amplified genomic DNA fragment into the pPD122.53(YFP) plasmid, which contains NLS 4 :: YFP. The fragment (cgaatactggaaatatgatg ---ttttttqcccaattcccata) contains the 5′ upstream region, 1 st exon, 1 st intron, 2 nd exon, and part of the 2 nd intron of lin-12. The genomic region contains 17 putative LAG-1-binding sites [seven in the 5′ regulatory region (3,400 bp), eight in the 1 st intron (1,519 bp), and two in the 5′ end of the 2 nd intron (115 bp)]. All 17 candidate binding sites were mutated in the lin-12(mutated LAG-1 binding sites)::YFP transcriptional fusion construct.
Site-directed mutagenesis of 13 LAG-1 binding sites in lag-1 and 17 sites in lin-12 was performed by sequentially ligating PCR fragments containing mutations in the sequences 'TCCCA' and 'TGGGA'. In lag-1, 13 LAG-1 binding sites were changed to 'TCACT', 'TCACT', 'TGCGT', 'TCACT', 'TCGTA', 'TCACT', 'TGGAT', 'TCACT', 'TCCAT', 'TCCTC', 'AGTGA', TGTGA', and 'AGTGA' sequences. In lin-12, 17 sites were to 'TGATC', 'TAGTA', 'ACCCA', 'TCATA', 'CGCGA', 'TGTGT', 'TGACT', 'TGCCT', 'TGTGT', 'TGAGA', 'AACCA', 'TCTCA', 'TTCGA', 'CCAGA', 'TGCAT', 'CTCGA', and 'GTCGA'.
The lag-1 cDNA or YFP was cloned after a cdh-3 AC regulatory element (known as mk 62-63), which is known to drive
